In a positive development for future and current outbreaks, experimental trials found that individuals have a 90% survival rate when treated with a new set of antibody-based Ebola treatments called REGN-EB3 and mAb114, which will now be deployed to all outbreak patients in the Democratic Republic of Congo. What do you think?
“I’ve been saying that there’s never been a better time to contract Ebola.”
Millicent Howell • Organ Wholesaler
“It’s too dangerous to give people an experimental treatment without a viable profit model in place first.”
Yusuf Frey • Adoxologist
“Let me guess: you can’t drink while you’re on it. No thanks.”
Greg Swift • Warning Designer